Field & Main Bank’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.31M | Sell |
10,618
-172
| -2% | -$38.2K | 0.67% | 43 |
|
|
2025
Q4 | $2.47M | Buy |
10,790
+169
| +2% | +$38.5K | 0.71% | 42 |
|
|
2025
Q3 | $2.46M | Buy |
10,621
+226
| +2% | +$46K | 0.73% | 40 |
|
|
2025
Q2 | $1.93M | Sell |
10,395
-20
| -0.2% | -$3.72K | 0.63% | 47 |
|
|
2025
Q1 | $2.18M | Sell |
10,415
-615
| -6% | -$120K | 0.77% | 41 |
|
|
2024
Q4 | $1.96M | Sell |
11,030
-320
| -3% | -$58.8K | 0.69% | 43 |
|
|
2024
Q3 | $2.24M | Sell |
11,350
-300
| -3% | -$56K | 0.8% | 39 |
|
|
2024
Q2 | $2M | Buy |
11,650
+26
| +0.2% | +$4.31K | 0.75% | 42 |
|
|
2024
Q1 | $2.12M | Sell |
11,624
-971
| -8% | -$167K | 0.82% | 40 |
|
|
2023
Q4 | $1.95M | Sell |
12,595
-437
| -3% | -$63.7K | 0.83% | 39 |
|
|
2023
Q3 | $1.94M | Sell |
13,032
-523
| -4% | -$76.8K | 0.91% | 35 |
|
|
2023
Q2 | $1.83M | Sell |
13,555
-155
| -1% | -$22.7K | 1.02% | 29 |
|
|
2023
Q1 | $2.18M | Sell |
13,710
-225
| -2% | -$34.4K | 1.3% | 18 |
|
|
2022
Q4 | $2.25M | Sell |
13,935
-329
| -2% | -$50.4K | 1.45% | 16 |
|
|
2022
Q3 | $1.92M | Sell |
14,264
-90
| -0.6% | -$12.9K | 1.29% | 19 |
|
|
2022
Q2 | $2.2M | Sell |
14,354
-211
| -1% | -$32.2K | 1.41% | 15 |
|
|
2022
Q1 | $2.36M | Sell |
14,565
-370
| -2% | -$53.7K | 1.43% | 17 |
|
|
2021
Q4 | $2.02M | Buy |
14,935
+410
| +3% | +$48.4K | 1.17% | 24 |
|
|
2021
Q3 | $1.57M | Sell |
14,525
-5
| -0% | -$571 | 1.03% | 30 |
|
|
2021
Q2 | $1.64M | Buy |
14,530
+435
| +3% | +$49K | 1.05% | 31 |
|
|
2021
Q1 | $1.53M | Buy |
14,095
+465
| +3% | +$49.7K | 1.09% | 27 |
|
|
2020
Q4 | $1.46M | Sell |
13,630
-70
| -0.5% | -$6.73K | 1.09% | 27 |
|
|
2020
Q3 | $1.2M | Buy |
13,700
+3,530
| +35% | +$332K | 0.93% | 37 |
|
|
2020
Q2 | $998K | Buy |
+10,170
| New | +$895K | 0.85% | 41 |
|
|
2019
Q4 | $835K | Sell |
9,425
-225
| -2% | -$18.7K | 0.69% | 50 |
|
|
2019
Q3 | $731K | Sell |
9,650
-1,610
| -14% | -$110K | 0.66% | 53 |
|
|
2019
Q2 | $818K | Sell |
11,260
-25
| -0.2% | -$1.97K | 0.75% | 46 |
|
|
2019
Q1 | $909K | Buy |
+11,285
| New | +$923K | 0.86% | 42 |
|
|
2018
Q3 | $1.12M | Buy |
11,830
+200
| +2% | +$19K | 1% | 30 |
|
|
2018
Q2 | $1.07M | Buy |
11,630
+605
| +5% | +$59.1K | 0.98% | 32 |
|
|
2018
Q1 | $1.04M | Buy |
11,025
+1,425
| +15% | +$157K | 1.02% | 26 |
|
|
2017
Q4 | $928K | Buy |
+9,600
| New | +$905K | 0.89% | 34 |
|
|
2015
Q2 | $811K | Buy |
12,065
+275
| +2% | +$18K | 0.77% | 51 |
|
|
2015
Q1 | $690K | Buy |
11,790
+730
| +7% | +$44.1K | 0.64% | 64 |
|
|
2014
Q4 | $724K | Buy |
11,060
+900
| +9% | +$56.7K | 0.68% | 59 |
|
|
2014
Q3 | $587K | Sell |
10,160
-2,540
| -20% | -$141K | 0.55% | 72 |
|
|
2014
Q2 | $717K | Hold |
12,700
| – | – | 0.67% | 64 |
|
|
2014
Q1 | $653K | Sell |
12,700
-1,152
| -8% | -$58.2K | 0.63% | 65 |
|
|
2013
Q4 | $731K | Buy |
+13,852
| New | +$681K | 0.71% | 62 |
|
Other funds holding ABBV
VCM
VPM
Field & Main Bank's ABBV Position: Q1 2026 in Review
Field & Main Bank reduced its AbbVie (ABBV) stake by 1.6% in Q1 2026, selling an estimated $38.2K and leaving 10,618 shares worth $2.31M. The position accounts for 0.67% of the portfolio, ranked #43.
Field & Main Bank first reported a position in ABBV in Q4 2013 and has held it in 39 quarters since. The position peaked at $2.47M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Field & Main Bank held 10,618 shares of AbbVie worth $2.31M as of Q1 2026.
- Field & Main Bank sold 172 AbbVie shares in Q1 2026, an estimated $38.2K.
- AbbVie made up 0.67% of Field & Main Bank's portfolio in Q1 2026, its #43 holding.
- Field & Main Bank first reported a position in AbbVie in Q4 2013 and has held it in 39 quarters since.
- Field & Main Bank's AbbVie position peaked at $2.47M in Q4 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Field & Main Bank's 13F filing for Q1 2026, filed 10 Apr 2026.